Spinal Muscular Atrophies

被引:124
作者
Darras, Basil T. [1 ]
机构
[1] Boston Childrens Hosp, Dept Neurol, Div Clin Neurol, Boston, MA 02115 USA
关键词
Spinal muscular atrophy; 5q SMA; Non-5q SMAs; Survival of motor neuron protein; Werdnig-Hoffmann disease; Dubowitz disease; Kugelberg-Welander disease; PLACEBO-CONTROLLED TRIAL; SMN MESSENGER-RNA; NATURAL-HISTORY; MOUSE MODEL; CLINICAL-TRIALS; PROTEIN-LEVELS; DOUBLE-BLIND; STEM-CELLS; PHENOTYPE; CLASSIFICATION;
D O I
10.1016/j.pcl.2015.03.010
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Spinal muscular atrophies (SMAs) are hereditary degenerative disorders of lower motor neurons associated with progressive muscle weakness and atrophy. Proximal 5q SMA is caused by decreased levels of the survival of motor neuron (SMN) protein and is the most common genetic cause of infant mortality. Its inheritance pattern is autosomal recessive, resulting from mutations involving the SMN1 gene on chromosome 5q13. Unlike other autosomal recessive diseases, the SMN gene has a unique structure (an inverted duplication) that presents potential therapeutic targets. Although there is currently no effective treatment of SMA, the field of translational research in this disorder is active and clinical trials are ongoing. Advances in the multidisciplinary supportive care of children with SMA also offer hope for improved life expectancy and quality of life.
引用
收藏
页码:743 / +
页数:26
相关论文
共 116 条
[1]   Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells [J].
Angelozzi, C. ;
Borgo, F. ;
Tiziano, F. D. ;
Martella, A. ;
Neri, G. ;
Brahe, C. .
JOURNAL OF MEDICAL GENETICS, 2008, 45 (01) :29-31
[2]   A population-based study of genotypic and phenotypic variability in children with spinal muscular atrophy [J].
Arkblad, Eva ;
Tulinius, Mar ;
Kroksmark, Anna-Karin ;
Henricsson, Mirja ;
Darin, Niklas .
ACTA PAEDIATRICA, 2009, 98 (05) :865-872
[4]   Arthrogryposis due to infantile neuronal degeneration associated with deletion of the SMNT gene [J].
Bingham, PM ;
Shen, N ;
Rennert, H ;
Rorke, LB ;
Black, AW ;
MarinPadilla, M ;
Nordgren, RE .
NEUROLOGY, 1997, 49 (03) :848-851
[5]   Antisense oligonucleotides and spinal muscular atrophy: skipping along [J].
Burghes, Arthur H. M. ;
McGovern, Vicki L. .
GENES & DEVELOPMENT, 2010, 24 (15) :1574-1579
[6]   Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy [J].
Butchbach, Matthew E. R. ;
Singh, Jasbir ;
Porsteinsdottir, Margret ;
Saieva, Luciano ;
Slominski, Elzbieta ;
Thurmond, John ;
Andresson, Thorkell ;
Zhang, Jun ;
Edwards, Jonathan D. ;
Simard, Louise R. ;
Pellizzoni, Livio ;
Jarecki, Jill ;
Burghes, Arthur H. M. ;
Gurney, Mark E. .
HUMAN MOLECULAR GENETICS, 2010, 19 (03) :454-467
[7]   INFANTILE MUSCULAR ATROPHY [J].
BYERS, RK ;
BANKER, BQ .
ARCHIVES OF NEUROLOGY, 1961, 5 (02) :140-&
[8]   Treatment of spinal muscular atrophy by sodium butyrate [J].
Chang, JG ;
Hsieh-Li, HM ;
Jong, YJ ;
Wang, NM ;
Tsai, CH ;
Li, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (17) :9808-9813
[9]   Randomized, double-blind, placebo-controlled trial of hydroxyurea in spinal muscular atrophy [J].
Chen, T. -H. ;
Chang, J. -G. ;
Yang, Y. -H. ;
Mai, H. -H. ;
Liang, W. -C. ;
Wu, Y. -C. ;
Wang, H. -Y. ;
Huang, Y. -B. ;
Wu, S. -M. ;
Chen, Y. -C. ;
Yang, S. -N. ;
Jong, Y. -J. .
NEUROLOGY, 2010, 75 (24) :2190-2197
[10]   Brown-Vialetto-van Laere and Fazio-Londe overlap syndromes: A clinical, biochemical and genetic study [J].
Ciccolella, Marianna ;
Catteruccia, Michela ;
Benedetti, Sabina ;
Moroni, Isabella ;
Uziel, Graziella ;
Pantaleoni, Chiara ;
Chiapparini, Luisa ;
Bizzi, Alberto ;
D'Amico, Adele ;
Fattori, Fabiana ;
Salsano, Maria Letizia ;
Pastore, Anna ;
Tozzi, Giulia ;
Piemonte, Fiorella ;
Bertini, Enrico .
NEUROMUSCULAR DISORDERS, 2012, 22 (12) :1075-1082